Borno residents give vote of confidence to malaria prevention drug  

0

By Michy Abraham in Maiduguri

Residents of Borno State have come out to give a vote of confidence to the monthly administration of malaria prevention drug.

The World Health Organisation and Borno State Government have administered malaria prevention drug every month (peak rainy period) during a four round Malaria Chemoprevention Campaigns (MPCs) in 25 of the 27 local government areas of Borno State, with Abadam and Marte inaccessible because of Boko Haram crisis.

The present round, which is the third in the series have had 2.1 million children between (3 and 59 months) attended to.

Speaking on Saturday to journalists, some parents said the drug administration has drastically reduced numbers of those affected by malaria.

One of the parents, Abba Ibrahim, who spoke to journalists at AK Amin IDP camp in Old Maiduguri said: “We are happy to present our children for the administration of the drug as it has drastically reduced the cases of malaria, our children since July have not fallen ill.”

He added that: “I must commend government and WHO for the initiative as it has reduced our hospital visits by over 50 percent.

A village head in the area, Bulama Musa thanked the men, heads of households for their commitment and cooperation which makes the implementation easy.

See also  COVID-19: Edo vaccinates over 33,800 community leaders, health workers, others

The World Health Organisation (WHO) and Borno State Government since the commencement of the exercise in July has taken the drug to 42 internally displaced persons (IDPs) camps in the troubled Northeast state of Borno.

The WHO National Cordinator Malaria Emergencies in Nigeria, Dr. Iniabasi Nglas, said the IDP camps are given special attention for there is high threat of malaria infection due to the environment.

She said record has shown that the treatment has reduced malaria morbidity in the state.

She revealed that during the first cycle, 1.9 million children were targeted but due to high reception 2.1 million children were administered with the drug.

She said: “In these part of the country, peak rainfall last three to four months and seasonal malaria Chemoprevention campaign which was flagged last month is to protect the Sahel areas. Within these three to four months when there is peak malaria incidences and prevalence.”

She noted that: “The programme is scheduled to happen during the peak rainfall to protect children between the age of 3 months to 59 months from malaria sickness. The programme is not only done here , but in other eight states in the country.

See also  Edo records six more COVID-19 deaths, 104 new confirmed cases

“Borno happened to be one of the states, but in Borno, WHO is taking the lead working with Borno state government with support from Global Fund. We are going to do this programme for five days, but each child will get a drug the first day, after that, the second and the third day doses are handed over to caregivers or parents and guided on what to do.”

The Borno State Coordinator, Malaria Elimination Programme, Mala Waziri said the parents brought their children out in large number to take the drugs as they identified the threat of malaria.

He however said there is no harm in the drug, stressing that it is never dangerous to child’s health.

He advised parents to discard the information on social media that the drug will adversely affect their children.

Waziri said the drug has been administered in the state since 2017 and record has shown that it has been able to drastically reduce cases of malaria morbidity in the state.

See also  ‎Jihadists kill five aid workers in Borno 
Untitled Document

You can always reach us through these channels

Facebook: https:/www.facebook.com/ancitymedia

Instagram: https://www.instagram.com/ancitymedia

Youtube Channel: https://youtube.com/@ancitymedia

 

Phone Numbers: 07062501185, 09038738731

E-Mail: info@ancity.com.ng, anambracity@gmail.com

Copyright.

This Post: Borno residents give vote of confidence to malaria prevention drug   was approved and published by Ancity Media Editor and may not be republished elsewhere without prior written permission from the Editor.


Get real time updates directly on you device, subscribe now.

Comments
Loading...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More